Detalhe da pesquisa
1.
Biological impact of iberdomide in patients with active systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477518
2.
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.
Lupus
; 30(8): 1283-1288, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957797
3.
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.
BMC Immunol
; 14: 34, 2013 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23915385
4.
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.
Clin Pharmacol Ther
; 106(2): 374-382, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30079582
5.
Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study.
BMJ Open
; 7(6): e016154, 2017 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28601838
6.
Treat to target in systemic lupus erythematosus / Tratamiento por objetivos en el lupus eritematoso sistémico
Rev. colomb. reumatol
; 28(supl.1): 101-106, Dec. 2021. tab
Artigo
em Inglês
| LILACS | ID: biblio-1361006
7.
Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Arthritis Rheum
; 58(11): 3319-29, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18975346